SORRENTO THERAPEUTICS INC (SRNE) Top Institutional Shareholders

SORRENTO THERAPEUTICS INC (SRNE) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $1.08M in SRNE holdings during the latest filing period.

Independent Financial Group, Llc is currently the largest disclosed institutional shareholder of SRNE tracked by InsiderSet, reporting ownership valued at approximately $1.08M in its June 30, 2021 SEC Form 13F filing.

The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed SRNE value among the investors covered in this analysis. Major shareholders include Independent Financial Group, Llc, Vsm Wealth Advisory, Llc, Huntington National Bank, and several other long-term asset managers with concentrated positions in SORRENTO THERAPEUTICS INC (SRNE).

This page ranks the largest institutional SRNE shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

4

Total Reported Value

$1.08M

Largest Holder

Independent Financial Group, Llc

Largest Position

$1.08M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

10

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Independent Financial Group, Llc0.01%218,000$1,080,993
Vsm Wealth Advisory, Llc0.00%110,100$363
Huntington National Bank0.00%5,001$16
Oakworth Capital, Inc.0.00%350$1

Frequently asked questions about SRNE

  • Who owns the most SRNE stock?

    The largest holders of SRNE are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for SORRENTO THERAPEUTICS INC (SRNE).

  • Is SRNE widely held by superinvestors?

    Many widely followed stocks like SRNE appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly SRNE is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.